Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001618784-17-000001
Filing Date
2017-01-24
Accepted
2017-01-24 15:04:07
Documents
1
Effectiveness Date
2017-01-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8793
  Complete submission text file 0001618784-17-000001.txt   9850
Mailing Address 30 ENTERPRISE SUITE 220 ALISO VIEJO CA 92656
Business Address 30 ENTERPRISE SUITE 220 ALISO VIEJO CA 92656 (949) 466-9248
Focal Therapeutics, Inc. (Filer) CIK: 0001618784 (see all company filings)

EIN.: 260530936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-279119 | Film No.: 17543560